Published in Hepatology on June 05, 1987
Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol (1989) 3.19
Direct detection of hepatitis B virus from dried blood spots by polymerase chain reaction amplification. J Clin Microbiol (1992) 0.96
Hepatitis B virus infection associated with hematopoietic tumors. Am J Pathol (1994) 0.96
Detection of hepatitis B virus DNA in sera from patients with chronic hepatitis B virus infection by DNA microarray method. J Clin Microbiol (2003) 0.91
DNA hybridization assay for congenital cytomegalovirus infection. J Clin Microbiol (1988) 0.75
The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology (2001) 3.25
HIV-1 sensitivity to zidovudine and clinical outcome in children. Lancet (1992) 2.93
Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol (2000) 2.89
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication. Gut (2009) 2.72
Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem (2001) 2.45
The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res (1997) 2.28
Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol (1999) 2.24
The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med (1995) 2.21
Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology (2000) 2.15
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology (1998) 2.05
Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med (1995) 2.04
Primary hepatocellular carcinoma. N Engl J Med (1991) 1.91
Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A (1982) 1.81
Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology (1996) 1.80
Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood (1988) 1.76
Effects of cytokines on the liver. Hepatology (1991) 1.76
Generation of stable mRNA fragments and translation of N-truncated proteins induced by antisense oligodeoxynucleotides. Mol Cell (2001) 1.74
An error model for protein quantification. Bioinformatics (2007) 1.72
Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem (1988) 1.69
Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol (1993) 1.63
Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med (1995) 1.58
Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br J Rheumatol (1998) 1.56
Control of the levels of free amino acids in plasma by the liver. Biochem Z (1965) 1.54
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology (1984) 1.48
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet (1997) 1.47
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. J Infect Dis (1999) 1.45
Location and type of mutation in the LIS1 gene do not predict phenotypic severity. Neurology (2007) 1.45
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J Control Release (2001) 1.45
Occurrence and management of hepatitis B virus reactivation following kidney transplantation. Clin Nephrol (1998) 1.44
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol (1994) 1.44
Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet (1999) 1.43
Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet (1984) 1.42
Identifying human immunodeficiency virus infection at birth: application of polymerase chain reaction to Guthrie cards. J Pediatr (1993) 1.41
Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol (2000) 1.41
[Local ablation of malignant lesions of the liver - potential applications and limitations of the different methods]. Z Gastroenterol (2004) 1.41
Actions of extracellular UTP and ATP in perfused rat liver. A comparative study. Eur J Biochem (1987) 1.40
[A rare cause of an indistinct liver lesion in an elderly woman]. Dtsch Med Wochenschr (2011) 1.39
[Blood culture collection]. Dtsch Med Wochenschr (2010) 1.39
Images in cardiovascular medicine. Idiopathic hypereosinophilic vasculitis. Circulation (1995) 1.39
[Liver diseases in pregnancy]. Dtsch Med Wochenschr (2008) 1.38
Cellular hydration state: an important determinant of protein catabolism in health and disease. Lancet (1993) 1.38
Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A (1983) 1.37
Surveillance of transcriptomes in basic military trainees with normal, febrile respiratory illness, and convalescent phenotypes. Genes Immun (2005) 1.37
Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Gastroenterology (1988) 1.35
Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol (2001) 1.33
Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol (2001) 1.32
Complete nucleotide sequence of a German duck hepatitis B virus. Nucleic Acids Res (1990) 1.31
Synthesis in cell culture of the gapped linear duplex DNA of the slow virus visna. Virology (1985) 1.27
Cell swelling inhibits proteolysis in perfused rat liver. Biochem J (1990) 1.27
Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology (1994) 1.26
Interactions between glutamine metabolism and cell-volume regulation in perfused rat liver. Eur J Biochem (1990) 1.25
Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles. Hepatology (1984) 1.25
Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology (1991) 1.23
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis (1980) 1.22
Functional hepatocyte heterogeneity in ammonia metabolism. The intercellular glutamine cycle. J Hepatol (1985) 1.22
A sphincterotome-based technique for selective transpapillary common bile duct cannulation. Gastrointest Endosc (2000) 1.21
Complete nucleotide sequence of a Chinese duck hepatitis B virus. Nucleic Acids Res (1990) 1.20
Regulation of cell function by the cellular hydration state. Am J Physiol (1994) 1.19
Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology (1990) 1.19
Serum markers of hepatocellular carcinoma. Semin Liver Dis (2006) 1.17
Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. Am J Obstet Gynecol (2001) 1.15
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol (2001) 1.15
Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology (1990) 1.14
Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest (2001) 1.14
A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B. Hepatology (1997) 1.13
Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med (1989) 1.13
Regulation of flux through glutaminase and glutamine synthetase in isolated perfused rat liver. Biochim Biophys Acta (1983) 1.13
Duck hepatitis B virus nucleocapsids formed by N-terminally extended or C-terminally truncated core proteins disintegrate during viral DNA maturation. J Virol (1998) 1.12
A simple and rapid method for the detection of RNA in formalin-fixed, paraffin-embedded tissues by PCR amplification. Biochem Biophys Res Commun (1991) 1.12
The information needs and fears of patients with inflammatory bowel disease. Hepatogastroenterology (1987) 1.11
Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study. Aliment Pharmacol Ther (2006) 1.10
alpha-Amanitin uptake into hepatocytes. Identification of hepatic membrane transport systems used by amatoxins. J Biol Chem (1986) 1.10
Refining the phenotype of alpha-1a Tubulin (TUBA1A) mutation in patients with classical lissencephaly. Clin Genet (2008) 1.10
Regulation of liver cell volume and proteolysis by glucagon and insulin. Biochem J (1991) 1.10
Liver cell volume and protein synthesis. Biochem J (1992) 1.10
Cell volume is a major determinant of proteolysis control in liver. FEBS Lett (1991) 1.10
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol (1990) 1.09
[Percutaneous liver biopsy]. Dtsch Med Wochenschr (2007) 1.09
Duck hepatitis B virus: DNA polymerase and reverse transcriptase activities of replicative complexes isolated from liver and their inhibition in vitro. Virology (1988) 1.09
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology (2000) 1.09
Inhibition of duck hepatitis B virus infection by lysosomotropic agents. Virology (1991) 1.08
Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study. Thromb Haemost (1979) 1.08
Inhibition of proteolysis by cell swelling in the liver requires intact microtubular structures. Biochem J (1995) 1.07
In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J (1993) 1.07
HIV-1 infected women and prenatal care utilization: barriers and facilitators. AIDS Patient Care STDS (2000) 1.06
Tuberculous colitis mimicking Crohn's disease. Am J Gastroenterol (1998) 1.06